Citius Oncology, Inc.(CTOR) - 2023 Q4 - Annual Report
Citius Oncology, Inc.(CTOR)2024-04-16 21:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Units, each consisting of one ordinary share, $0.0001 par value, and one right entitling the holder to receive two-tenths of an ordinary share TENKU The Nasdaq Stock Market LLC Ordinary shares, par value $0.0001 per share TENK The Nasdaq Stock Market LLC Rights, each right entitling the holder to receive twotenths of one ordinary shareTENKR The Nasdaq Stock ...